← FDA DRUG APPROVALS

FDA NDA · NDA010911

BUCLADIN-S

Sponsor: STUART PHARMS

APPLICATION
NDA010911
TYPE
NDA
ORIGINAL APPROVAL
1957-04-08
LATEST ACTION
1957-04-08
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

BUCLADIN-SDiscontinued
BUCLIZINE HYDROCHLORIDE 50MG · TABLET · ORAL

Approval history

1957-04-08Type 4 - New Combination · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →